198 assets in Ischemic Stroke

Therapeutic assets addressing Ischemic Stroke, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS) Ischemic Stroke	Shanghai Yueyang Integrated Medicine Hospital	P2/3	B (57)
Alirocumab Ischemic Stroke	Sun U. Kwon	P4	B (57)
Baricitinib Ischemic Stroke	The First Affiliated Hospital of University of Science and Technology of China	P2/3	B (57)
Bovis Calculus Stativus Ischemic Stroke	Xiang Luo	P2/3	B (57)
Dulaglutide Ischemic Stroke	National University of Singapore	P2/3	B (57)
Evolocumab Ischemic Stroke	Xiang Luo	P4	B (57)
Ginkgo Diterpene Lactone Meglumine Ischemic Stroke	Ying Gao	P2/3	B (57)
Hydroxyurea Ischemic Stroke	Vanderbilt University Medical Center	P2/3	B (57)
Physiologic Sodium Chloride Solution Ischemic Stroke	Zhujiang Hospital	P3	B (57)
Recombinant Human Tissue Kallikrein Ischemic Stroke	DiaMedica Therapeutics Inc	P2/3	B (57)
scp776 Ischemic Stroke	Silver Creek Pharmaceuticals	P2	B (57)
Yiqihuayu Decoction Ischemic Stroke	Ying Gao	P2/3	B (57)
3K3A-APC Ischemic Stroke	ZZ Biotech, LLC	P3	B (56)
Agomelatine Ischemic Stroke	First Affiliated Hospital, Sun Yat-Sen University	P4	B (56)
Apsolol Ischemic Stroke	Second Affiliated Hospital, School of Medicine, Zhejiang University	P3	B (56)
Dexmedetomidine Ischemic Stroke	Beijing Chao Yang Hospital	P4	B (56)
Fluvastatin Ischemic Stroke	Prof. dr. Nathalie van der Velde	P4	B (56)
Glenzocimab Ischemic Stroke	Fondation Ophtalmologique Adolphe de Rothschild	P2/3	B (56)
Glycine Ischemic Stroke	Pharmasoft	P4	B (56)
gm1 Ischemic Stroke	Xuanwu Hospital, Beijing	P4	B (56)
M-Sympathol Ischemic Stroke	Yonsei University	P3	B (56)
neu2000kwl Ischemic Stroke	GNT Pharma	P3	B (56)
Oxygen Ischemic Stroke	Beijing Tiantan Hospital	P3	B (56)
Semaglutide Ischemic Stroke	Population Health Research Institute	P3	B (56)
Shpl-49 Ischemic Stroke	Shanghai Hutchison Pharmaceuticals Limited	P3	B (56)
Tocilizumab Ischemic Stroke	Capital Medical University	P3	B (56)
Xingnaojing Ischemic Stroke	Ying Gao	P4	B (56)
Dodecafluoropentane Ischemic Stroke	NuvOx LLC	P2/3	CCC (54)
Human Fibrinogen Ischemic Stroke	Azienda Usl di Bologna	P3	CCC (54)
Recombinant Human Prourokinase For Ischemic Stroke	Beijing Tiantan Hospital	P3	CCC (54)
Trimetazidine Ischemic Stroke	Ain Shams University	P3	CCC (54)
Ttyp01 Tables Ischemic Stroke	Shanghai Auzone Biological Technology Co., Ltd.	P3	CCC (54)
xy03-ea Ischemic Stroke	Shijiazhuang Yiling Pharmaceutical Co. Ltd	P2/3	CCC (54)
y-3 for Ischemic Stroke	Beijing Tiantan Hospital	P3	CCC (54)
Amantadine Ischemic Stroke	University of Pennsylvania	P2	CCC (53)
Bevifibatide Citrate Ischemic Stroke	Zhujiang Hospital	P2	CCC (53)
Gly-Ser-Ser(Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-Oh Ischemic Stroke	Rijnstate Hospital	P2	CCC (53)
Perphenazine Ischemic Stroke	Maastricht University	P2	CCC (53)
Propylthiouracil Ischemic Stroke	Maastricht University	P2	CCC (53)
Sarecycline Ischemic Stroke	Beijing Tiantan Hospital	P2	CCC (53)
Tadalafil Ischemic Stroke	Christina Kruuse	P2	CCC (53)
Verapamil Slow Release Ischemic Stroke	Justin Fraser	P1/2	CCC (53)
XENON Ischemic Stroke	Negovsky Reanimatology Research Institute	P3	CCC (53)
2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER Ischemic Stroke	Xuanwu Hospital, Beijing	P2	CCC (52)
6-(3-(4-(O-METHOXYPHENYL)-1-PIPERAZINYL)PROPYLAMINO)-1,3-DIMETHYLURACIL Ischemic Stroke	Second Affiliated Hospital, School of Medicine, Zhejiang University	P3	CCC (52)
Acetylleucine Ischemic Stroke	Kafrelsheikh University	P3	CCC (52)
Citicoline Ischemic Stroke	Kafrelsheikh University	P3	CCC (52)
Cord Blood (Plasma Depleted) Ischemic Stroke	StemCyte, Inc.	P2	CCC (52)
Dimethyloxobuthylphosphonilmethylate Ischemic Stroke	Tatchempharmpreparaty, JSC	P3	CCC (52)
GD-11 Ischemic Stroke	Beijing Tiantan Hospital	P3	CCC (52)

Showing 51 to 100 of 198 assets

PreviousPage 2 of 4Next